Literature DB >> 20042028

Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm.

Asa Hammar1, Lin Sørensen, Guro Ardal, Ketil Joachim Oedegaard, Rune Kroken, Atle Roness, Anders Lund.   

Abstract

The aim of the study was to investigate automatic and effortful information processing with the Stroop paradigm in a long term perspective in patients with major depressive disorder (MDD). Patients were tested at two test occasions: at inclusion with a Hamilton Depression Rating Scale (HDRS) score >18, and after 6 months, when most patients had experienced symptom reduction. The Stroop paradigm is considered to measure aspects of attention and executive functioning and consists of three conditions/cards: naming the color of the patches (Color), reading of the color-words (Word) and naming the ink color of color-words (Color-Word). The Color-Word condition is proved to be the most cognitive demanding task and requires the proband to actively suppress interference and is therefore considered to require more effortful information processing, whereas naming the color of the patches and reading the color-words are expected to be more automatic and less cognitive demanding. A homogenous group of 19 patients with unipolar recurrent MDD according to DSM-IV and a HDRS score of >18 were included in the study. A control group was individually matched for age, gender and level of education. Depressed patients performed equal to the control group on the Color and Word cards at both test occasions. However, the patients were impaired compared with the control group on the Color-Word card task at both test occasions. Thus, the depressed patients showed no improvement of effortful attention/executive performance as a function of symptom reduction. The results indicate that the depressed patients showed impaired cognitive performance on cognitive demanding tasks when symptomatic and that this impairment prevailed after 6 months, despite significant improvement in their depressive symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 20042028     DOI: 10.1111/j.1467-9450.2009.00765.x

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  18 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 2.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 3.  Physical Exercise and Neuroinflammation in Major Depressive Disorder.

Authors:  Zuleide M Ignácio; Renato S da Silva; Marcos E Plissari; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2019-06-21       Impact factor: 5.590

4.  Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers.

Authors:  Fadi T Maalouf; David Brent; Luke Clark; Lucy Tavitian; Rebecca Munnell McHugh; Barbara J Sahakian; Mary L Phillips
Journal:  J Affect Disord       Date:  2011-05-26       Impact factor: 4.839

5.  White matter correlates of impaired attention control in major depressive disorder and healthy volunteers.

Authors:  Mina M Rizk; Harry Rubin-Falcone; John Keilp; Jeffrey M Miller; M Elizabeth Sublette; Ainsley Burke; Maria A Oquendo; Ahmed M Kamal; Mohamed A Abdelhameed; J John Mann
Journal:  J Affect Disord       Date:  2017-06-30       Impact factor: 4.839

6.  Dispositional fear, negative affectivity, and neuroimaging response to visually suppressed emotional faces.

Authors:  Nathalie Vizueta; Christopher J Patrick; Yi Jiang; Kathleen M Thomas; Sheng He
Journal:  Neuroimage       Date:  2011-07-14       Impact factor: 6.556

7.  Neurological and psychiatric diseases and their unique cognitive profiles: implications for nursing practice and research.

Authors:  David E Vance; Joan E Dodson; Jason Watkins; Bridgett H Kennedy; Norman L Keltner
Journal:  J Neurosci Nurs       Date:  2013-04       Impact factor: 1.230

Review 8.  Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.

Authors:  B Guardiola-Lemaitre; C De Bodinat; P Delagrange; M J Millan; C Munoz; E Mocaër
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 9.  Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Authors:  Alexandria N Tartt; Madeline B Mariani; Rene Hen; J John Mann; Maura Boldrini
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

10.  A follow-up study of first episode major depressive disorder. Impairment in inhibition and semantic fluency-potential predictors for relapse?

Authors:  Marit Schmid; Asa Hammar
Journal:  Front Psychol       Date:  2013-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.